It has been suggested that thrombin indirectly induces cellular rearrangements by activating PAR1 and transactivating the epidermal growth factor receptor (EGFR and/or HER2) poor prognosis factors for breast cancer patients, which exerts its effects exclusively through intracellular signals. Here, ERBB2 is linked to breast cancer.